Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
about
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future researchDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionBuprenorphine: a unique drug with complex pharmacologyDual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsAgonist replacement for stimulant dependence: a review of clinical researchAccess to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment.Bioavailability of sublingual buprenorphine.Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THCUnderstanding polydrug use: review of heroin and cocaine co-use.Agonist replacement therapy for cocaine dependence: a translational review.Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment OrganizationsBudgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain.Opioid maintenance: a comparative review of pharmacological strategies.State policy influence on the early diffusion of buprenorphine in community treatment programsAbuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.Self administration of cocaine in monkeys receiving LAAM acutely or chronicallyA Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations.Maintainence Treatment of Opioid Dependence with Tramadol.Training primary health care professionals to provide buprenorphine and LAAM treatment.Use of slow-release oral morphine for the treatment of opioid dependence.Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse?Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction.Current Status of Professional Training in the Addictions.Buprenorphine and naloxone interactions in opiate-dependent volunteers*
P2860
Q22241485-BCE6568E-5DA2-48DD-B39D-A29AAE366180Q24641896-DF052B75-1FC6-4596-8DF3-2EF2BE2ABD4EQ24642980-4496568B-0624-48BF-9CE9-99070459607DQ24647786-9940F04C-D86C-459B-9B62-870C47338C28Q27014854-1FB685A1-FFE2-4309-990E-102414D84B3FQ33639077-080DC458-4B3F-4B8F-8CEC-57B9B14D93FCQ34417674-2973D000-0F12-4F8B-9689-FEAFC16D2F67Q34950909-A5513877-E4D8-4170-957A-005CD6A22AF2Q35030844-3DDAB4AB-0EFA-4708-B464-7296B9D970F5Q35799846-87E4238A-421E-4DDF-ABD0-C48B3EC6E368Q36058075-2FFA8B49-0623-4B6E-9083-E9C8E84CA197Q36110773-FB4EFCEE-8295-4D49-B6F1-642EF7DC1722Q36681297-D33C28DB-6A98-4C7F-96DF-DE82FE3240BCQ36766544-C6C904AF-F2E4-4769-9E55-37B3176D5150Q36936280-3D617FD2-7A13-4CB0-B973-827FB5BCFF21Q37145523-7B15EA8B-71BD-44B5-BFC6-0675C29ED422Q37238353-8F8D489D-C518-4C9C-808E-CFF044B19FF1Q38786260-F13542C3-5F5A-4810-B6EA-085BF4EE5902Q40965310-6DE79C10-4959-43B5-A551-B64A823426FDQ41669477-1583F835-DE40-4D24-9BF4-7702EE31C419Q41707219-CE744378-3313-4FF8-9887-180349288905Q44221015-6B53C8CA-9EC3-4B50-810A-433B106E159EQ44349573-672E4050-426B-4D8B-8F81-9D102F0565D2Q45222099-4C060666-992D-48C0-95BA-7FC50E55E818Q46722139-D0B90674-9693-4DC0-AAD3-644994914F6FQ47099872-4565C358-DB4B-4372-A639-5C43B5F4B060Q52282001-E0C6DF6B-DFF4-49DB-B613-077F0D1A75ECQ56764300-5AA4B70C-25CF-4A55-95AD-D23B07E84011
P2860
Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Substitution pharmacotherapies ...... one to LAAM and buprenorphine.
@en
type
label
Substitution pharmacotherapies ...... one to LAAM and buprenorphine.
@en
prefLabel
Substitution pharmacotherapies ...... one to LAAM and buprenorphine.
@en
P2093
P2860
P1476
Substitution pharmacotherapies ...... one to LAAM and buprenorphine.
@en
P2093
P2860
P304
P356
10.1080/02791072.1994.10472259
P577
1994-04-01T00:00:00Z